Halfords Group PLC (HFD)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 255.50 |
|---|---|
| 52-week range | 123.80 – 282.50 |
| Return, 1 month / 3 months | −1.5% / +8.7% |
| Return, 1 year / 3 years | +79.5% / +54.5% |
| Trend | Uptrend |
| RSI (14) | 45 |
| Volatility (1 year) | 33.4% |
| Worst drawdown (1 year) | -17.1% |
| Average daily value traded | 342.64M GBX |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Halfords Group is a British retailer focused on motoring and cycling. It runs retail stores and service centres that supply car parts, accessories, tools, bicycles and cycling equipment, along with child car seats and outdoor leisure goods. Its garages and fitting bays provide car servicing, MOT testing, tyre fitting and bicycle repair, serving motorists and cyclists across the United Kingdom. The company is based in the United Kingdom and sells both through its shops and online.
Halfords Group PLC trades under the code HFD on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Halfords Group PLC (HFD) trades on the London Exchange in UK. It last closed at GBX 255.50 on 22 October 2026.
Its price-based Market X-Ray is 83 out of 100 (a strong price profile), ranking 18 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 79.5% and over the last three months it rose 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 35.2% | ||
| From 52-week high | -8.8% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.7% | ||
| 6-month return | 89.9% | ||
| 12-month return, skipping the last month | 82.3% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.1% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 342.64M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −6.2% |
|---|---|
| 1 month | −1.5% |
| 3 months | +8.7% |
| 6 months | +89.9% |
| 1 year | +79.5% |
| 3 years | +54.5% |
| 5 years | +19.2% |
Signals
| 50-day / 200-day average | 254.82 / 189.00 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.84 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | GBP 0.0600 |
| 11 Dec 2025 | GBP 0.0300 |
| 7 Aug 2025 | GBP 0.0580 |
| 12 Dec 2024 | GBP 0.0300 |
| 8 Aug 2024 | GBP 0.0500 |
| 14 Dec 2023 | GBP 0.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.